AzTrials
AzTrials

Perceived StressCBSMNCT03883321

EssaiClinique_CBSM

An observational study of Perceived Stress, run by University Hospital, Grenoble at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The CBSM is a program combining cognitive and behavioral therapies, relaxation provided in groups of 8 to 10 patients. This program has demonstrated benefits in stress management skills, adaptive strategies, anxiety, quality of life, social inclusion, medication adherence, depression, therapeutic alliance, and general… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Perceived Stress
What is being tested?
Cognitive behavioral stress management
How many people
25 participants
Where
1 siteFrance
Study dates
1 Sep 2018to 1 Feb 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Patient being treated for cancer, undergoing treatment or having completed treatment, at any stage and suffering from chronic pain

Who may be able to join

  • Over 18,
  • Currently treated or treated for cancer (solid or otherwise), any stage combined.
  • With chronic pain related to cancer or its treatment
  • Never benefited from the management of stress by this technique
  • Knowing how to read, write and speak French
  • Person affiliated with social security or beneficiary of an equivalent plan.

Who cannot join

  • Life expectancy of less than 6 months
  • Patients unable to travel for 10 sessions on the structure
  • Person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Grenoble University Hospital

    La Tronche, Isère, 30700

Other trials in France

About this study

Official title: Interest of Cognitive-behavioral Therapies Based on the CBSM (Cognitive Behavior Stress Management) for the Management of Patients Suffering From Pain Related to Cancer.

The CBSM is a program combining cognitive and behavioral therapies, relaxation provided in groups of 8 to 10 patients. This program has demonstrated benefits in stress management skills, adaptive strategies, anxiety, quality of life, social inclusion, medication adherence, depression, therapeutic alliance, and general well-being. It would also improve breast cancer survival after adjuvant therapy. This program has been put in place at the center of pain for patients with cancer pain in any stage. This study aims to evaluate the benefits of this technique on a patient population suffering from chronic pain related to cancer.

Read the detailed description

Methodology: Observational study, prospective, open, mono-centric, comparative, evaluating a psychosocial intervention type CBSM versus no intervention (group "waiting list").

Main Objective: To evaluate the impact of the implementation of a "CBSM" program on the stress management capacities of a pilot group of 30 patients followed at the pain center of Grenoble-Alpes University Hospital for chronic pain related to cancer or its treatment, compared to a control group "waiting list"

Primary Outcome: Measurement of emotional stress (PSS14)

Secondary objective:

Determine patients' interest in this program and the feasibility of the program.

Determine patient satisfaction with this program To evaluate the impact of the program on the quality of life of patients. To evaluate the impact of the program on the handicap perceived by the patients in connection with their pains.

Evaluation of the impact of the program on the pain of the patients (on the daily behavior).

Evaluation of the impact of the program on depression and anxiety. Determine the impact of the 3-month program of the 9th session on the different dimensions described above

Inclusion criterion:

  • Over 18,
  • Currently treated or treated for cancer (solid or otherwise), any stage combined.
  • With chronic pain related to cancer or its treatment
  • Never benefited from the management of stress by this technique
  • Knowing how to read, write and speak French
  • Person affiliated with social security or beneficiary of an equivalent plan.

Criteria of non-inclusion:

  • Life expectancy of less than 6 months
  • Patients unable to travel for 10 sessions on the structure (CHUGA)
  • Person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure.

Number of patients included: a minimum of 30 patients including, a minimum of 15 in the CBSM group and a minimum of 15 in the "waiting list" group (patients included in the waiting list group will participate in the CBSM program but will not be not analyzed in the CBSM group)

Being tested
Cognitive behavioral stress management
Keywords
stress management, CBSM, Chronic Pain, Cancer
Medical subject headings
Chronic Pain, Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive behavioral stress managementOther

    Management of patients in 10 group sessions with cognitive and behavioral therapies associated with relaxation in order to learn how to manage stress

Study groups in NCT03883321
Study groupRoleWhat they receive
CBSMPatients included in this group participate in the CBSM program. They attend 10 sessions of stress management according to the CBSM program, 9 take place over 3 months and the tenth session takes place 3 months after the 9th session. The session is composed of relaxation and cognitive and behavioral therapy, which is carried out in groups of 8 to 10 patients
Receives: Other: Cognitive behavioral stress management
Waiting listThe CBSM group is compared to the "waiting list" group that does not benefit from the CBSM program. After completing their assessment in the "waiting list" group, patients in this group will be integrated into the CBSM group but will not be evaluated as such.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of emotional stress (PSS14)

    assessment of the evolution of stress over a period of 3 months: Questionnaire PSS14

    Measured: evaluation at the beginning of the meeting and at 9 weeks

Secondary outcomes (6)
  1. Inclusion rate

    ratio of number of patients who agreed to participate in the program to the number of patients to whom the program was proposed

    Measured: up to 18 months

  2. Satisfaction

    Satisfaction rate of CBSM program with a questionnaire

    Measured: at 6 months

  3. Measurement of quality of life

    Evaluate the impact of the program on the quality of life of patients with a Physical and Mental Health Summary Scales with 12 questions (SF12) questionnaire

    Measured: evaluation at the beginning of the meeting and at 9 weeks and then at 3 months

  4. Pain Disability Index (PDI)

    Evaluate the impact of the program on disability perceived by patients in relation to their pain: PDI questionnaire

    Measured: evaluation at the beginning of the meeting and at 9 weeks and then at 3 months

  5. concise questionnaire on pain short version (QCD)

    Evaluation of the impact of the program on patients' pain (on daily behavior) with QCD questionnaire

    Measured: evaluation at the beginning of the meeting and at 9 weeks and then at 3 months

  6. Hospital Anxiety and Depression Scale (HADS)

    Evaluation of the impact of the program on depression and anxiety with HADS questionnaire

    Measured: evaluation at the beginning of the meeting and at 9 weeks and then at 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2019
  2. Study start1 Sep 2018
  3. Primary completion1 Feb 2020
  4. Study completion1 Feb 2020

Why it stopped: few patient feedback and principal investigator disponibility

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03883321
Sponsor's protocol ID
38RC17.291
Other IDs
2017-A02618-45
Acronym
CBSM
Status last verified
Aug 2020
First submitted
15 Jan 2019
Last updated
2 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Perceived Stress, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 2 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: few patient feedback and principal investigator disponibility). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of emotional stress (PSS14) (time frame: evaluation at the beginning of the meeting and at 9 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2020; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in